• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Search Orphan Drug Designations and Approvals

  • Print
  • Share
  • E-mail
-
Generic Name: Adeno-associated viral vector encoding the human frataxin (FXN) gene, AAVrh.10hFXN
Date Designated: 06/24/2021
Orphan Designation: Treatment of patients with cardiac disease associated with Friedreich’s Ataxia (FA)
Orphan Designation Status: Designated
FDA Orphan Approval Status: Not FDA Approved for Orphan Indication
Lexeo Therapeutics
430 East 29th Str
14th Floor
New York, New York 10016
United States

The sponsor address listed is the last reported by the sponsor to OOPD.

*Exclusivity Protected Indications are shown for approvals from 01/01/2013 to the present.
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-
-